Phenotype: decreased circulating fructosamine level

Definition decrease in the concentration in the blood of total non enzymatic glycated proteins in the blood

Synonyms
  • decreased circulating glycated serum protein level
  • decreased circulating glycated serum protein level
  • reduced circulating fructosamine level
  • reduced circulating fructosamine level
  • reduced circulating glycated serum protein level
  • reduced circulating GSP level
  • decreased circulating GSP level
Show more

MP browserMP:0010088

Phenotype associations stats

1.74% of tested genes with null mutations on a B6N genetic background have a phenotype association to decreased circulating fructosamine level (40/2298)

1.41% females (31/2192) 1.63% males (36/2214)

Select a parameter    



Gene variants with decreased circulating fructosamine level

Total number of significant genotype-phenotype associations: 67

Gene / Allele Zygosity Sex Life Stage Phenotype Procedure | Parameter Phenotyping Center | Source P Value Data
Snx8
Snx8tm2a(EUCOMM)Hmgu
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 1.4E-13
Comt
Comttm1b(EUCOMM)Wtsi
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 3.46E-11
Itch
Itchtm1b(EUCOMM)Hmgu
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 3.09E-9
Vgf
Vgfem1(IMPC)H
HOM Female postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 3.87E-9
4933402N03Rik
4933402N03Riktm2a(KOMP)Wtsi
HOM Female postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 1.43E-8
Prmt3
Prmt3tm1a(EUCOMM)Wtsi
HET Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Creatine kinase WTSI | EuroPhenome 6.77E-8
Gdap2
Gdap2em1(IMPC)Wtsi
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 1.67E-7
Akap9
Akap9tm1a(KOMP)Wtsi
HET Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | EuroPhenome 2.28E-7
Clpp
Clpptm1a(EUCOMM)Wtsi
HOM Female postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 2.3E-7
Pank3
Pank3tm1b(KOMP)Mbp
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 2.48E-7
Usp54
Usp54tm1b(KOMP)Wtsi
HOM Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 3.71E-7
4933434E20Rik
4933434E20Riktm1a(EUCOMM)Wtsi
HET Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 7.29E-7
Galnt18
Galnt18tm1b(KOMP)Wtsi
HOM Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 1.03E-6
Fbxo7
Fbxo7tm1a(EUCOMM)Wtsi
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 1.08E-6
Hexb
Hexbtm1b(EUCOMM)Hmgu
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 1.62E-6
Sik3
Sik3tm1a(EUCOMM)Hmgu
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 2.21E-6
Micu2
Micu2tm1a(EUCOMM)Wtsi
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 3.09E-6
Eps8l2
Eps8l2tm1b(EUCOMM)Wtsi
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 4.29E-6
Ap3s2
Ap3s2tm1b(EUCOMM)Hmgu
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 5.71E-6
Slc7a8
Slc7a8tm2b(EUCOMM)Hmgu
HET Female postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 6.14E-6
Tff1
Tff1tm1a(EUCOMM)Wtsi
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 9.78E-6
Usp21
Usp21tm1a(EUCOMM)Wtsi
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 1.01E-5
Izumo1r
Izumo1rtm2a(KOMP)Wtsi
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 1.34E-5
Chd7
Chd7Whi
HET Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | EuroPhenome 1.59E-5
Col4a2
Col4a2em1(IMPC)Wtsi
HET Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 1.85E-5
Serpinb9b
Serpinb9bem1(IMPC)Wtsi
HOM Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 1.98E-5
Map3k1
Map3k1tm1a(KOMP)Wtsi
HET Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 2.25E-5
Armc2
Armc2tm1b(EUCOMM)Hmgu
HET Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 2.36E-5
Usp15
Usp15tm1b(EUCOMM)Wtsi
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 2.39E-5
Aff3
Aff3tm1a(EUCOMM)Wtsi
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 2.76E-5
Mybphl
Mybphltm1b(KOMP)Wtsi
HET Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 3.22E-5
Exosc9
Exosc9tm1b(EUCOMM)Wtsi
HET Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 3.35E-5
Dbn1
Dbn1tm1a(KOMP)Wtsi
HOM Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | MGP 4.05E-5
Tbc1d22a
Tbc1d22atm1b(KOMP)Wtsi
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 4.27E-5
Commd9
Commd9tm1b(KOMP)Wtsi
HET Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 5.63E-5
Arpc4
Arpc4tm1a(EUCOMM)Wtsi
HET Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | EuroPhenome 6.17E-5
Irgm1
Irgm1em1(IMPC)Wtsi
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 7.39E-5
Pes1
Pes1tm1b(EUCOMM)Wtsi
HET Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 8.54E-5
Wrap53
Wrap53tm1b(EUCOMM)Wtsi
HET Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 9.17E-5
Atp5md
Atp5mdtm1b(EUCOMM)Wtsi
HOM Female Male postnatal decreased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 9.59E-5

Download data as: TSV XLS